CDK1 and leukemia: We established a highly robust method for cell cycle analysis in U937 and MOLT4 human leukemia cell lines using CDK1 inhibitor RO-3306 for synchronizing cells in G2/M phase followed by sample collection and determination of cell cycle phase distribution with flow cytometry.